[The Hungarian adaptation of Anxiety disorder module in the SCID-I/NP research version].
The SCID-I structured clinical interview based on the DSM-IV-TR criteria is widely used in internationally, but the reliability and validity of its Hungarian version has not been investigated. This paper presents the results of the first validity and reliability study of the Hungarian version of the SCID-I/NP's (Structured Clinical Interview for DSM-IV-TR Axis I Disorders Non-patient Edition) Anxiety Disorders module. The language adaptation of the diagnostic interview and of the user's guide was conducted in accordance with the WHO recommendations. SCID-I/NP Overview and Screening module; SCID-I/NP Module F: Anxiety Disorders; Tests providing external validity: Beck Anxiety Inventory (BAI), Adult ADHD Self-Report Scale (ASRS), Buss-Perry Aggression Questionnaire (AQ), Alcohol Use Disorders Identification Test (AUDIT). The study sample consisted of 741 patients attended at three GP's offices. The trial's duration was two months. GLM analysis, Chi-square test, Fisher's exact test, Kappa and weighted Kappa statistics. Results showed a significant interrater-agreement between the rater pairs. For screening modules yealding negative results, the false-negative analysis indicated a subthreshold positive diagnosis in one case. External validity analyses showed significant discrepancies in terms of gender, marital status and past psychiatric treatments among the three sample groups including those with diagnosis present, subthreshold diagnosis, diagnosis absent. In terms of the psychometric scales, we found significant differences on the BAI and the ASRS in these groups. In the case of AQ we found significant differences in total score and in the factors of hostility and anger: the diagnosis present group showed significantly elevated severity values compared to the other two groups. The Anxiety Disorders Module of the SCID-I/NP is suitable for detecting anxiety disorders in non-psychiatric population, and hence enables the early admission for treatment.